subscribeSubscribe
price-trendAsk Us
Summit Therapeutics Presents Ri-CoDIFy Trial Results for Ridinilazole at IDWeek

Summit Therapeutics Presents Ri-CoDIFy Trial Results for Ridinilazole at IDWeek
GLOBENEWSWIRE
20 Oct 2022
Share Share
Summit to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole

Summit to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole
GLOBENEWSWIRE
13 Oct 2022
Share Share
Summit will take scenic route up FDA mountain

Summit will take scenic route up FDA mountain
Annalee Armstrong FIERCEBIOTECH
14 Jul 2022
Share Share
Summit Therapeutics Provides Update on Ridinilazole

Summit Therapeutics Provides Update on Ridinilazole
GLOBENEWSWIRE
14 Jul 2022
Share Share
Summit turns to partnerships for failed C. difficile med

Summit turns to partnerships for failed C. difficile med
Max Bayerf FIERCEBIOTECH
19 Mar 2022
Share Share
Bob Duggan`s new antibiotic play fails a Phase III trial; upsets investors

Bob Duggan`s new antibiotic play fails a Phase III trial; upsets investors
N. DeFeudis ENDPTS
22 Dec 2021
Share Share
Summit Doses 1st Pt in Ph 3 Clinical Trials of Precision Antibiotic Ridinilazole

Summit Doses 1st Pt in Ph 3 Clinical Trials of Precision Antibiotic Ridinilazole
GLOBENEWSWIRE
13 Feb 2019
Share Share
Potential of Precision Antibiotic Ridinilazole to Treat C. difficile Infection

Potential of Precision Antibiotic Ridinilazole to Treat C. difficile Infection
GLOBENEWSWIRE
26 Sep 2018
Share Share